Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 941-899-8 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1993
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- None
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 993
- Report date:
- 1993
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- yes
- Remarks:
- only four tester strains tested; no tester strain to detect cross-linking mutagens was included.
- Principles of method if other than guideline:
- Guideline followed
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Reaction mass of 1,7-Naphthalenedisulfonic acid, 4-[[3-[(2-bromo-1-oxo-2-propen-1-yl)amino]benzoyl]amino]-6-[2-[5-[(2-bromo-1-oxo-2-propen-1-yl)amino]-2-sulfophenyl]diazenyl]-5-hydroxy-, sodium salt (1:3) and Trisodium 6-[{5-[(2-bromoacryloyl)amino]-2-sulfonatophenyl}diazenyl]-4-({3-[(2,3-dibromopropanoyl)amino]benzoyl}amino)-5-hydroxynaphthalene-1,7-disulfonate
- EC Number:
- 941-899-8
- Cas Number:
- 1625603-53-3
- Molecular formula:
- C29H18Br2N5Na3O13S3 . C29H19Br3N5Na3O13S3
- IUPAC Name:
- Reaction mass of 1,7-Naphthalenedisulfonic acid, 4-[[3-[(2-bromo-1-oxo-2-propen-1-yl)amino]benzoyl]amino]-6-[2-[5-[(2-bromo-1-oxo-2-propen-1-yl)amino]-2-sulfophenyl]diazenyl]-5-hydroxy-, sodium salt (1:3) and Trisodium 6-[{5-[(2-bromoacryloyl)amino]-2-sulfonatophenyl}diazenyl]-4-({3-[(2,3-dibromopropanoyl)amino]benzoyl}amino)-5-hydroxynaphthalene-1,7-disulfonate
- Test material form:
- other: solid
Constituent 1
- Specific details on test material used for the study:
- None
Method
- Target gene:
- The strains are derived from S. typhimurium strain LT2 and due to a mutation in the histidine locus are histidine dependent. Additionally due to the "deep rough" (rfa-minus) mutation they possess a faulty lipopolysaccharide envelope which enables substances to penetrate the cell wall more easily. A further mutation causes a reduction in the activity of an excision repair system. The latter alteration includes mutational processes in the nitrate reductase and biotin genes produced in a UV-sensitive area of the gene named "uvrB-minus". In the strains TA 98, TA 100 and TA 102 the R-factor plasmid pKM 101 carries the ampicillin resistance marker. The strain TA 102 does not contain the uvrB-_mutation. Additionally TA 102 contains the multicopy plasmid pAQl, which carries the hisG428 mutation and a tetracyclin resistance gene. TA 102 contains the ochre mutation in hisG gene.
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Metabolic activation:
- with and without
- Test concentrations with justification for top dose:
- Experiment 1: 33.3, 100.0, 333.3, 1000.0, 2500.0 and 5000.0 µg/plate
Experiment 2: 500.0, 1000.0, 2000.0, 3000.0, 4000.0 and 5000.0 µg/plate - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: A.bidest.
- Justification for choice of solvent/vehicle: The solvent was chosen because of its solubility properties.
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- methylmethanesulfonate
- other: 4-nitro-o-phenylene-diamine
- Details on test system and experimental conditions:
- The bacterial strains were obtained from Dr. Heinz Träger, Knoll AG, D-6700 Ludwigshafen, F.R.G.
STORAGE:
The strain cultures were stored as stock cultures in ampoules with nutrient broth + 5 % DMSO in liquid nitrogen.
PRECULTURES:
From the thawed ampoules of the strains 0.5 ml bacterial suspension was transferred to 250 ml Erlenmeyer flasks containing 20 ml nutrient medium. This nutrient medium contains per litre:
8 g Merck Nutrient Broth
5 g NaCl
The bacterial culture was incubated in a shaking water bath for 10 hours at 37 °C.
SELECTIVE AGAR:
2.0 % Vogel-Bonner-Glucose-Minimal-Agar was used as selective agar. Each petri dish was filled with 20 ml of this nutrient medium. Sterilisations were performed at 121 °C in an autoclave.
OVERLAY AGAR:
The overlay agar contains per litre:
6.0 g Merck Agar Agar
6.0 g NaCl
10.5 mg L-histidine x HCl x H20
12.2 mg biotin
Sterilisations were performed at 121 °C in an autoclave.
MAMMALIAN MICROSOMAL FRACTION S9 MIX:
S9 (Preparation by C C R):
The S9 liver microsomal fraction was obtained from the liver of 8-12 weeks old male Wistar rats, strain WU (SAVO-Ivanovas, med. Versuchstierzuchten GmbH, D-7964 Kisslegg, F.R.G.; weight approx. 150 - 200 g) which received a single i.p. injection of 500 mg/kg b.w. Aroclor 1254 (Antechnika, D-7500 Karlsruhe, F.R.G.) in olive oil 5 days previously.
After cervical dislocation the livers of the animals were removed, washed in 150 mM KCl and homogenised. The homogenate, diluted 1+3 in KCl was centrifuged cold at 9,000 g for 10 minutes. A stock of the supernatant containing the microsomes was frozen in ampoules of 2, 3 or 5 ml and stored at -70 °C. Small numbers of the ampoules are kept at -20 °C for only several weeks before use. The standardisation of the protein content was made using the analysis kit of Bio-Rad Laboratories, D-8000 München: Bio-Rad protein assay, Catalogue 500 000 6.
The protein concentration in the S9 preparation was 31.6 mg/ml (lot 060792).
S9 MIX:
Before the experiment an appropriate quantity of S9 supernatant was thawed and mixed with S9 cofactor solution. The amount of S9 supernatant was 15 % v/v. The composition of the cofactor solution was concentrated to yield the following concentrations in the S9 mix:
8 mM MgCl2
33 mM KCl
5 mM glucose-6-phosphate
5 mM NADP
in 100 mM sodium-ortho-phosphate-buffer, pH 7.4.
During the experiment the S9 mix was stored in an ice bath. The S9 mix preparation was performed according to Ames et al.
PRE-EXPERIMENT FOR TOXICITY:
To evaluate the toxicity of the test article a prestudy was performed with strains TA 98 and TA 100. 8 concentrations were tested for toxicity and mutation induction with each 3 plates. The experimental conditions in this pre-experiment were the same as described below for the experiment I (plate incorporation
test).
Toxicity of the test article may be evidenced by a reduction in the number of spontaneous revertants, a clearing of the bacterial background lawn, or by degree of survival of treated cultures.
DOSE SELECTION:
According to the results of the pre-experiment the concentrations applied in the main experiments were chosen.
Experiment I was performed with the normal concentration grading. Due to the mutagenic effect obtained in experiment I, experiment II was performed as well as a plate incorporation assay. Additionally the concentration grading was designed to explore the linear part of the dose-response curve obtained in experiment I. Therefore, a more narrow concentration range (between 1000.0 and 5000.0 µg/plate) was selected in experiment II.
The maximum concentration was 5000.0 µg/plate in experiment I and II. The concentration range included two logarithmic decades in experiment I and one logarithmic decade in experiment II. In this study six adequately spaced concentrations were tested. Two independent experiments were performed. - Evaluation criteria:
- A test article is considered as positive if either a dose related and reproducible increase in the number of revertants or a significant and reproducible increase for at least one test concentration is induced.
A test article producing neither a dose related and reproducible increase in the number of revertants nor a significant and reproducible positive response at any one of the test points is considered non-mutagenic in this system.
A significant response is described as follows:
A test article is considered as mutagenic if in strain TA 100 and TA 102 the number of reversions is at least twice as high and in strains TA 1535, TA 1537, and TA 98 it is at least three times higher as compared to the spontaneous reversion rate.
Also, a dose-dependent and reproducible increase in the number of revertants is regarded as an indication of possibly existing mutagenic potential of the test article regardless whether the highest dose induced the above described enhancement factors or not. - Statistics:
- No appropriate statistical method is available
Results and discussion
Test results
- Key result
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- positive
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- Toxic effects, evidenced by a reduction in the number of revertants, occurred in strain TA 1537 (without S9 mix) and in strain TA 102 (with S9 mix) at the highest investigated dose in experiment I.
The plates incubated with the test article showed normal background growth up to 5000.0 µg/plate with and without S9 mix in all strains used.
Up to the highest investigated dose a significant, dose-dependent increase in the number of revertants was observed in the strains TA 1535 and TA 100 with and without metabolic activation in experiment I and II.
No substantial increases in revertant colony numbers were observed following treatment with FAT 92'348/A (Lanasol Rot 2G roh trocken) at any dose level, either in the presence or absence of metabolic activation (S9 mix) in the strains TA 1537, TA 98 and TA 102.
A slight increase in revertant colony numbers was found in strain TA 98 (without S9 mix) at 5000.0 µg/plate in experiment I and in strain TA 102 at 3000.0 µg/plate (with S9 mix) in experiment II. These results are considered not to be biologically relevant since they could not be reproduced in the independent experiment.
Appropriate reference mutagens were used as positive controls and showed a distinct increase in induced revertant colonies. - Remarks on result:
- other: all strains/cell types tested
Any other information on results incl. tables
None
Applicant's summary and conclusion
- Conclusions:
- FAT 92'348/A (Lanasol Rot 2G roh trocken) is considered to be mutagenic in this Salmonella typhimurium reverse mutation assay.
- Executive summary:
This study was performed to investigate the potential of FAT 92348/A (Lanasol Rot 2G roh trocken) to induce gene mutations according to the plate incorporation test using the Salmonella typhimurium strains TA 1535, TA 1537, TA 98, TA 100, and TA 102.
This study followed the procedures indicated by the following internationally accepted guidelines and recommendations:
First Addendum to OECD Guidelines for Testing of Chemicals - Section 4, No. 471, "Salmonella typhimurium, Reverse Mutation Assay", adopted May 26, 1983 and EEC Directive 79/831, Annex V, B 14. The study was performed in compliance with GLP.
The assay was performed in two independent experiments both with and without liver microsomal activation. Each concentration, including the controls, was tested in triplicate. The test article was tested at the following concentrations:
Experiment I : 33.3; 100.0; 333.3; 1000.0; 2500.0 and 5000.0 µg/plate
Experiment II: 500.0; 1000.0; 2000.0; 3000.0; 4000.0 and 5000.0 µg/plate
Toxic effects, evidenced by a reduction in the number of revertants, occurred in strain TA 1537 (without S9 mix) and in strain TA 102 (with S9 mix) at the highest investigated dose in experiment I.
The plates incubated with the test article showed normal background growth up to 5000.0 µg/plate with and without S9 mix in all strains used. Up to the highest investigated dose a significant dose-dependent increase in the number of revertants was observed in the strains TA 1535 and TA 100 with and without metabolic activation in experiment I and II. Appropriate reference mutagens were used as positive controls and showed a distinct increase of induced revertant colonies.
In conclusion, it can be stated that during the described mutagenicity test and under the experimental conditions reported, the test article induced point mutations by base pair changes in the genome of the strains TA 1535 and TA 100. Therefore, FAT 92'348/A (Lanasol Rot 2G roh trocken) is considered to be mutagenic in this Salmonella typhimurium reverse mutation assay.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
